These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31089983)

  • 1. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
    Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
    Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ICRT-3 on Wnt signaling pathway in head and neck cancer.
    Sogutlu F; Kayabasi C; Ozmen Yelken B; Asik A; Gasimli R; Dogan F; Yilmaz Süslüer S; Biray Avcı C; Gunduz C
    J Cell Biochem; 2019 Jan; 120(1):380-395. PubMed ID: 30145828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells.
    Kleszcz R; Frąckowiak M; Dorna D; Paluszczak J
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
    Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
    Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of lncRNA LINC00473 promotes radioresistance of HNSCC cells through activating Wnt/β-catenin signaling pathway.
    Han PB; Ji XJ; Zhang M; Gao LY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7305-7313. PubMed ID: 30468475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
    Yang F; Zeng Q; Yu G; Li S; Wang CY
    Cell Signal; 2006 May; 18(5):679-87. PubMed ID: 16084063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wnt Signaling Pathway Inhibitors Improve the Therapeutic Activity of Glycolysis Modulators against Tongue Cancer Cells.
    Kleszcz R; Paluszczak J
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
    Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma.
    Liu H; Chen X; Yang X; Li M; Zhang W; Zhang G; Zhan X; Cao L; Li W; Huang Z; Gao R
    Oncol Lett; 2020 Dec; 20(6):394. PubMed ID: 33193854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
    Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
    Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang QH; Hu QX; Xie D; Chang B; Miao HG; Wang YG; Liu DZ; Li XD
    Integr Cancer Ther; 2019; 18():1534735419890917. PubMed ID: 31855073
    [No Abstract]   [Full Text] [Related]  

  • 14. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets.
    Milan TM; Eskenazi APE; Oliveira LD; Silva GD; Bighetti-Trevisan RL; Freitas GP; Almeida LO
    Cell Signal; 2023 Sep; 109():110773. PubMed ID: 37331417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
    Shah K; Panchal S; Patel B
    Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM83A promotes proliferation and metastasis via Wnt/β-catenin signaling in head neck squamous cell carcinoma.
    Ji H; Song H; Wang Z; Jiao P; Xu J; Li X; Du H; Wu H; Zhong Y
    J Transl Med; 2021 Oct; 19(1):423. PubMed ID: 34641907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas.
    Li M; Ding X; Zhang Y; Li X; Zhou H; Yang L; Li Y; Yang P; Zhang X; Hu J; Nice E; Wu H; Xu H
    Cell Death Dis; 2020 Aug; 11(8):672. PubMed ID: 32826863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA human leucocyte antigen complex group-18 HCG18 (HCG18) promoted cell proliferation and migration in head and neck squamous cell carcinoma through cyclin D1-WNT pathway.
    Mao B; Wang F; Zhang J; Li Q; Ying K
    Bioengineered; 2022 Apr; 13(4):9425-9434. PubMed ID: 35389764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis.
    Peña-Oyarzún D; Flores T; Torres VA; Quest AFG; Lobos-González L; Kretschmar C; Contreras P; Maturana-Ramírez A; Criollo A; Reyes M
    Clin Cancer Res; 2024 Jan; 30(1):209-223. PubMed ID: 37812478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.